Abstract
Angiotensin II mediates both growth and death pathways in the young developing heart and the failing heart. Although stimulation of both processes by the same agent might seem counterproductive, the cell is capable of specifically regulating the process that will dominate. The secret behind the specificity of the response lies in the characteristics of the plethora of signaling pathways initiated by angiotensin II. It is generally felt that alterations in these pathways play a pivotal role in both the normal development of the young heart and the onset of pathology in the failing heart. Although the recent introduction of transgenic animals has proven valuable in assessing the contribution of specific pathways in the regulation of growth and apoptosis, more information is required on the interplay between these pathways and mediators of growth and apoptosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akishita, M., Ito, M., Lehtonen, J.Y., Daviet, L., Dzau, V.J., and Horiuchi, M. 1999. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J. Clin. Invest. 103:63-71.
Aplin, M., Christensen, G.L., Schneider, M., Heydorn, A., Gammeltoft, S., Kjolbye, A.L., Sheikh, S.P., and Hansen, J.L. 2007a. The angiotensin type 1 receptor activates extracellular signal-related kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and Langendorff-perfused hearts. Basic Res. Pharmacol. Toxicol. 100:289-295.
Aplin, M., Christensen, G.L., Schneider, M., Heydorn, A., Gammeltoft, S., Kjolbye, A.L., Sheikh, S.P., and Hansen, J.L. 2007b. Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes. Basic Res. Pharmacol. Toxicol. 100:296-301.
Bader, M. 2002. Role of the local renin-angiotensin system in cardiac damage: a minireview fo-cusing on transgenic animal models. J. Mol. Cell. Cardiol. 34:1455-1462.
Bascands, J.-L., Girolami, J.-P., Troly, M., Escargueil-Blanc, I., Nazzal, D., Salvayre, R., and Blaes, N. 2001. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth mus-cle cells. Hypertension 38:1294-1299.
Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susini, C., Strosberg, A.D., and Nahmias, C. 1997. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem. J. 325:449-454.
Bendall, J.K., Cave, A.C., Heymes, C., Gall, N., and Shah, A.M. 2002. Pivotal role of a gp91phox -containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105:293-296.
Bhaskaran, M., Reddy, K., Radhakrishnan, N., Franki, N., Ding, G., and Singhal, P.C. 2003. An-giotensin II induces apoptosis in renal proximal tubular cells. Am. J. Physiol. 284:F955-F965.
Bokemeyer, D., Schmi, U., and Kramer, H.J. 2000. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Kidney Int. 58:549-558.
Bonnet, F., Cao, Z., and Cooper, M.E. 2001. Apoptosis and angiotensin II: Yet another renal regu-latory system? Exp. Nephrol. 9:295-300.
Booz, G.W., Day, J.N.E., and Baker, K.M. 2002. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunc-tion, and heart failure. J. Mol. Cell. Cardiol. 34:1443-1453.
Clempus, R.E., and Griendling, K.K. 2006. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 71:216-225.
Cui, T.-X., Nakagami, H., Nahmias, C., Shiuchi, T., Takeda-Matsubara, Y., Li, J.-M., Wu, L., Iwai, M., and Horiuchi, M. 2002. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Mol. Endocrinol. 16:2113-2123.
deBlois, D., Tea, B.-S., Dam, T.-V., Tremblay, J., and Hamet, P. 1997. Smooth muscle apop-tosis during vascular regression in spontaneously hypertensive rats. Hypertension 29:340-349.
Diep, Q.N., El Mabrouk, M., Yue, P., and Schiffrin, E.L. 2002. Effect of AT1 receptor block-ade on cardiac apoptosis in angiotensin II-induced hypertension. Am. J. Physiol. 282:H1635-H1641.
Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., and Zeiher, A.M. 1997. Angiotensin II in-duces apoptosis of human endothelial cells: Protective effect of nitric oxide. Circ. Res. 81:970-976.
Dimmeler, S., Breitschopf, K., Haendeler, J., and Zeiher, A.M. 1999. Dephosphorylation targets Bcl-2 for ubiquitinin-dependent degradation: a link between apoptosis and the proteasome path-way. J. Exp. Med. 189:1815-1822.
Ding, G., Reddy, K., Kapasi, A.A., Franki, N., Gibbons, N., Kasinath, B.S., and Singhal, P.C. 2002. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am. J. Physiol. 283:F173-F180.
Dostal, D.E., and Baker, K.M. 1999. The cardiac renin-angiotensin system: conceptual, or a regu-lator of cardiac function? Circ. Res. 85:643-650.
Dostal, D.E., Hunt, R.A., Kule, C.E., Bhat, G.J., Karoor, V., McWhinney, C.D., and Baker, K.M. 1997. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac ef-fects and signal transduction pathways. J. Mol. Cell. Cardiol. 29:2893-2902.
Eguchi, S., and Inagami, T. 2000. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul. Peptides 91:13-20.
Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E.D., Kawakatsu, H., Owada, K.M., Hirata, Y., Marumo, F., and Inagami, T. 1998. Calciumdependent epidermal growth factor receptor transactivaiton mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273:8890-8896.
Frank, G.D., Eguchi, S., Inagami, T., and Motley, E.D. 2001. N-acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor re-ceptor. Biochem. Biophys. Res. Commun. 280:1116-1119.
Gendron, L., Payet, M.D., and Gallo-Payet, N. 2003. The angiotensin type 2 receptor of an-giotensin II and neuronal differentiation: from observations to mechanisms. J. Mol. Endocrinol. 31:359-372.
Giasson, E., and Meloche, S. 1995. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J. Biol. Chem. 270:5225-5231.
Godeny, M.D., and Sayeski, P.P. 2006a. ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCζ-controlled ERK1/2 ac-tivity within the nucleus. Am. J. Physiol. 291:C1297-1307.
Godeny, M.D., and Sayeski, P.P. 2006b. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1. Am. J. Physiol. 291:C1308-1317.
Grammatopoulos, T.N., Morris, K., Bachar, C., Moore, S., Andres, R., and Weyhenmeyer, J.A. 2004. Angiotensin II attenuates chemical hypoxia-induced caspase-3 activation in primary cor-tical neuronal cultures. Brain Res. Bull. 62:297-303.
Grishko, V., Pastukh, V., Solodushko, V., Gillespie, M., Azuma, J., and Schaffer, S. 2003. Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: Role of DNA damage. Am. J. Physiol. 285:H2364-2372.
Haendeler, J., Tischler, V., Hoffmann, J., Zeiher, A.M., and Dimmeler, S. 2004. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett. 577:427-433.
Hafizi, S., Wang, X., Chester, A.H., Yacoub, M.H., and Proud, C.G. 2004. ANG II activates ef-fectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am. J. Physiol. 287:H1232-H1238.
Halestrap, A.P., Clarke, S.J., and Javadov, S.A. 2004. Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc. Res. 61:372-385.
Hamawaki, M., Coffman, T.M., Lashus, A., Koide, M., Zile, M.R., Oliverio, M.I., DeFreyte, G., Cooper, G. 4th , and Carabello, B.A. 1998. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am. J. Physiol. 274:H868-H873.
Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., and Dzau, V.J. 1997. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272:19022-19026.
Hou, M., Pantev, E., Moeller, S., Erlinge, D., and Edvinsson, L. 2000. Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+ -sensitive PKC-dependent tyrosine kinase pathway. Acta Physiol. Scand. 168:301-309.
Huang, X.C., Richards, E.M., and Sumners, C. 1996. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J. Biol. Chem. 271:15635-15641.
Iijima, Y., Laser, M., Shiraishi, H., Willey, C.D., Sundaravadivel, B., Xu, L., McDermott, P.J., and Kuppuswamy, D. 2002. Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J. Biol. Chem. 277:23065-23075.
Inagami, T., and Senbonmatsu, T. 2001. Dual effects of angiotensin II type 2 receptor on cardio-vascular hypertrophy. Trends Cardiovasc. Med. 11:324-328.
Joehren, O., Dendorfer, A., and Dominiak, P. 2004. Cardiovascular and renal function of an-giotensin II type-2 receptors. Cardiovasc. Res. 62:460-467.
Kaschina, E., and Unger, T. 2003. Angiotensin AT1/AT2 receptors: Regulation, signaling and func-tion. Blood Pressure 12:70-88.
Lehtonen, J.Y.A., Horiuchi, M., Daviet, L., Akishita, M., and Dzau, V.J. 1999. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J. Biol. Chem. 274:16901-16906.
Li, D., Yang, B., Philips, M.I., and Mehta, J.L. 1999. Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am. J. Physiol. 276:H786-H792.
Li, Y., Song, Y.-H., Mohler, J., and Delafontaine, P. 2006. ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. Am. J. Physiol. 290:H2116-H2123.
Lijnen, P., and Petrov, V. 1999. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J. Mol. Cell. Cardiol. 31:949-970.
Lin, K.T., Xue, J.Y., Nomen, M., Spur, B., and Wong, P.Y. 1995. Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem. 270:16487-16490.
Mel’nikova, N.P., Timoshin, S.S., Jivotova, E.Y., Pelliniemi, L.J., Jokinen, E., and Abdelwahid, E. 2006. Angiotensin II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats. Int. J. Cardiol. 112:219-222.
Mifune, M., Ohtsu, H., Suzuki, H., Nakashima, H., Brailoiu, E., Dun, N.J., Frank, G.D., Inagami, T., Higashiyama, S., Thomas, W.G., Eckhart, A.D., Dempsey, P.J., and Eguchi, S. 2005. G protein coupling and second messenger generation are indispensable for metalloproteasedependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J. Biol. Chem. 280:26592-26599.
Miura, S.-I., and Karnik, S.S. 2000. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J. 19:4026-4035.
Miura, S.-I., Karnik, S.S., and Saku, K. 2005. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stim-ulation. J. Biol. Chem. 280:18237-18244.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffmann, B., and Reed, J.C. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
Murasawa, S., Mori, Y., Nozawa, Y., Gotoh, N., Shibuya, M., Masaki, H., Maruyama, K., Tsutsumi, Y., Moriguchi, Y., Shibasaki, Y., Tanaka, Y., Iwasaka, T., Inada, M., and Matsubara, H. 1998a. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+ /calmodulin-dependent transactivation of epidermal growth factor receptor. Circ. Res. 82:1338-1348.
Murasawa, S., Mori, Y., Nozawa, Y., Masaki, H., Maruyama, K., Tsutsumi, Y., Moriguchi, Y., Shibasaki, Y., Tanaka, Y., Iwasaka, T., Inada, M., and Matsubara, H. 1998b. Role of calcium-sensitive tyrosine kinase Pyk2/CAKβ/RAFTK in angiotensin II-induced Ras/ERK signaling. Hypertension 32:668-675.
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., and Namba, M. 1998. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation 98:794-799.
Ohashi, H., Takagi, H., Oh, H., Suzuma, K., Suzuma, I., Miyamoto, N., Uemura, A., Watanabe, D., Murakami, T., Sugaya, T., Fukamizu, A., and Honda, Y. 2004. Phosphatidylinositol-3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothe-lial cells by governing surviving expression and suppression of caspase-3 activity. Circ. Res. 94:785-793.
Olson, E.R., Naugle, J.E., Zhang, X., Bomser, J.A., and Meszaros, J.G. 2005. Inhibition of car-diac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am. J. Physiol. 288:H1131-H1138.
Papp, M., Li, X., Zhuang, J., Wang, R., and Uhal, B.D. 2002. Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II. Am. J. Physiol. 282:L713-L718.
Pierzchalski, P., Reiss, K., Cheng, W., Cirielli, C., Kajstura, J., Nitahara, J.A., Rizk, M., Capogrossi, M.C., and Anversa, P. 1997. P53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell Res. 234:57-65.
Pollman, M.J., Yamada, T., Horiuchi, M., and Gibbons, G.H. 1996. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Circ. Res. 79:748-756.
Ricci, C., Pastukh, V., and Schaffer, S. 2005. Involvement of the mitochondrial permeability tran-sition pore in angiotensin II-mediated apoptosis. Exp. Clin. Cardiol. 10:160-164.
Roessig, L., Hermann, C., Haendeler, J., Assmus, B., Zeiher, A.M., and Dimmeler, S. 2002. Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates en-dothelial cell apoptosis. Basic Res. Cardiol. 97:1-8.
Rostovtseva, T.K., Antonsson, B., Suzuki, M., Youle, R.J., Colombini, M., and Bezrukov, S.M. 2004. Bid, but not bax, regulates VDAC channels. J. Biol. Chem. 279:13575-13583.
Ruf, S., Piper, H.M., and Schlueter, K.-D. 2002. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro. Pfluegers Arch. Eur. J. Physiol. 443:483-490.
Sadoshima, J.-I., and Izumo, S. 1993. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ. Res. 73:424-438.
Sadoshima, J.-I., and Izumo, S. 1995. Rapamycin selectively inhibits angiotensin II-induced in-crease in protein synthesis in cardiac myocytes in vitro: potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ. Res. 77:1040-1052.
Sadoshima, J., Qiu, Z., Morgan, J.P., and Izumo, S. 1995. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes: The critical role of Ca2+ -dependent signaling. Circ. Res. 76:1-15.
Schroeder, D., Heger, J., Piper, H.M., and Euler, G. 2006. Angiotensin II stimulates apoptosis via TGF-β1 signaling in ventricular cardiomyocytes of rat. J. Mol. Med. 84:975-983.
Schunkert, H., Sadoshima, J.-I., Cornelius, T., Kagaya, Y., Weinberg, E.O., Izumo, S., Riegger, G., and Lorell, B.H. 1995. Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ. Res. 76:489-497.
Seshiah, P.N., Weber, D.S., Rocic, P., Valppu, L., Taniyama, Y., and Griendling, K.K. 2002. An-giotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91:406-413.
Seta, K., Nanamori, M., Modrall, J.G., Neubig, R.R., and Sadoshima, J. 2002. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J. Biol. Chem. 277:9268-9277.
Shenoy, U.V., Richards, E.M., Huang, X.C., and Sumners, C. 1999. Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology 140:500-509.
Shimizu, S., Narita, M., and Tsujimoto, Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487.
Steckelings, U.M., Kaschina, E., and Unger, T. 2005. The AT2 receptor—A matter of love and hate. Peptides 26:1401-1409.
Sun, Y., and Weber, K.T. 1998. Cardiac remodeling by fibrous tissue: role of local factors and circulating hormones. Ann. Med. 30(Suppl. 1):3-8.
Suzuki, J., Iwai, M., Nakagami, H., Wu, L., Chen, R., Sugaya, T., Hamada, M., Hiwada, K., and Horiuchi, M. 2002. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 106:847-853.
Tian, B., Liu, J., Bitterman, P., and Bache, R.J. 2003. Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of Akt/PKB. Am. J. Physiol. 285:H1105-H1112.
Touyz, R.M., and Schiffrin, E.L. 2000. Signal transduction mechanisms mediating the physiologi-cal and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52:639-672.
Touyz, R.M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., and Schiffrin, E.L. 2003. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can. J. Physiol. Pharmacol. 81:159-167.
Ushio-Fukai, M., Griendling, K.K., Becker, P.L., Hilenski, L., Halleran, S., and Alexander, R.W. 2001. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxy-gen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21:489-495.
Wang, D., Yu, X., and Brecher, P. 1999. Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation. J. Biol. Chem. 274:24342-24348.
Wang, D., Yu, X., Cohen, R.A., and Brecher, P. 2000. Distinct effects of N-acetylcysteine and nitric oxide on angiotensin II-induced epidermal growth factor receptor phosphorylation and intracellular Ca2+ levels. J. Biol. Chem. 275:12223-12230.
Wang, X.P., Zhang, R., Wu, K., Wu, L., and Dong, Y. 2004. Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas 29:264-270.
Wenzel, S., Abdallah, Y., Helmig, S., Schaefer, C., Piper, H.M., and Schlueter, K.-D. 2006. Con-tribution of PI 3-kinase isoforms to angiotensin II- and α-adrenoceptor-mediated signalling pathways in cardiomyocytes. Cardiovasc. Res. 71: 352-362.
Yamada, T., Horiuchi, M., and Dzau, V.J. 1996. Angiotensin II type 2 receptor mediates pro-grammed cell death. Proc. Natl. Acad. Sci. USA 93:156-160.
Yamada, T., Akishita, M., Pollman, M.J., Gibbons, G.H., Dzau, V.J., and Horiuchi, M. 1998. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antago-nizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci. 63:PL289-PL295.
Yamazaki, T., and Yazaki, Y. 1997. Is there major involvement of the renin-angiotensin system in cardiac hypertrophy? Circ. Res. 81:639-642.
Zhai, P., Yamamoto, M., Galeotti, J., Liu, J., Masurekar, M., Thaisz, J., Irie, K., Holle, E., Yu, X., Kupershmidt, S., Roden, D.M., Wagner, T., Yatani, A., Vatner, D.E., Vatner, S.F., and Sadoshima, J. 2005. Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq /GαI coupling causes hypertrophy and bradycardia in transgenic mice. J. Clin. Invest. 115:3045-3056.
Zhai, P., Galeotti, J., Liu, J., Holle, E., Yu, X., Wagner, T., and Sadoshima, J. 2006. An an-giotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ. Res. 99:528-536.
Zhang, Y., Griendling, K.K., Dikalova, A., Owens, G.K., and Taylor, W.R. 2005. Vascular hypertro-phy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2 O2 . Hypertension 46:732-737.
Zou, Y., Komuro, I., Yamazaki, T., Kudoh, S., Aikawa, R., Zhu, W., Shiojima, I., Hiroi, Y., Tobe, K., Kadowaki, T., and Yazaki, Y. 1998. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gβγ subunit, Src family, and Ras in cardiac fibroblasts. Circ. Res. 82:337-345.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schaffer, S.W., Mozaffari, M.S. (2008). Angiotensin II Signaling: Cell Growth and Apoptosis. In: Srivastava, A.K., Anand-Srivastava, M.B. (eds) Signal Transduction in the Cardiovascular System in Health and Disease. Advances in Biochemistry in Health and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09552-3_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-09552-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09551-6
Online ISBN: 978-0-387-09552-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)